dexamethasone,lenalidomide,bortezomib
takeda
['mds', 'determination', 'aml,(-streamline),(-seamless),(-kamloops)', 'mmsm']
determination : med age 55-57 ( 60+). high-risk 20%. 19% black pts! - 85% in asct arm got asct. - mpfs 67.5 vs 46.2 mos in favor of asct. no os diff. - mpfs 55 vs 17 mos for high-risk w/asct vs not
- 2nd cancers 10%. more all in vrd alone; more aml/mds w/asct. #mmsm #asco22
Assistant Professor at the University of Chicago, specializing in (vanquishing) plasma cell disorders. I tweet about: Myeloma and MRD. COI: https://t.co/1DEICEb1Q7